arrow
R

Roberto Piva

University of Turin
H指数:52
被引数:8,296

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Audrito et al. NAMPT Over-Expression Recapitulates the BRAF Inhibitor Resistant Phenotype Plasticity in Melanoma. Cancers 2020, 12, 3855

更正:Audrito等人。NAMPT过表达重演了黑素瘤中BRAF抑制剂抗性的表型可塑性。Cancers 2020, 12, 3855

Cancers
IF4.4
2026-07-290
OA
MDM2 Drives Proteasome Inhibitor Resistance and Represents a TP53-Independent Therapeutic Vulnerability in Multiple Myeloma

MDM2驱动蛋白酶体抑制剂耐药性,并在多发性骨髓瘤中代表一种TP53非依赖性的治疗易损性

Cells
IF5.2
2026-05-010
OA
Common genomic and transcriptomic signatures in Richter transformation highlight druggable vulnerabilities and guide drug repurposing strategies

Richter转化的共同基因组学和转录组学特征突显可用药脆弱性并指导药物重定位策略

Leukemia
IF13.4
2026-04-140
OAAI
Wiskott-Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma (vol 25, pg 130, 2019)

Wiskott-Aldrich综合征蛋白(WASP)是T细胞淋巴瘤中的肿瘤抑制因子(卷25,页130,2019)

2026-03-010
PRE
Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma

溶素 (K) 特异性脱甲基酶1抑制增强蛋白酶体抑制剂反应并克服多发性骨髓瘤的耐药性

2023-08-105
OAAI
Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteins

长链非编码RNA NEAT1的激活通过支持DNA修复蛋白的正调控环而导致多发性骨髓瘤细胞的生存优势

2022-09-0813
OAAI
Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension (vol 33, pg 631, 2020)
2020-06-304
OAAI
Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma
2019-03-1917
OAAI
Wiskott-Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma
2018-12-0357
OAAI
The AP-1-BATF and-BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma
LEUKEMIA
IF13.4
2018-03-2866
OAAI